{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:00Z","timestamp":1791908640267,"version":"4.3.4"},"reference-count":65,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":2409,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T00:00:00Z","timestamp":1561680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Angiotensin-converting enzyme 2 (ACE2) is a homologue of angiotensin-converting enzyme (ACE) and produces angiotensin peptides (APs), such as angiotensin 1-9 and 1-7 that are vasodilatory and natriuretic, and act to counterbalance angiotensin II.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Evidence of ACE2 can be found in tissues and plasma of dogs. Equilibrium concentrations of renin angiotensin aldosterone system (RAAS) APs differ in dogs with heart disease compared to healthy dogs and recombinant human ACE2 (rhACE2) alters relative concentrations of APs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Forty-nine dogs with and 34 dogs without heart disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Immunohistochemistry and assays for tissue and plasma ACE2 activity and equilibrium concentrations of plasma RAAS APs were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Immunolabeling for ACE2 was present in kidney and myocardial tissue. Median plasma ACE2 activity was significantly increased in dogs with congestive heart failure (CHF; 6.9 mU\/mg; interquartile range [IQR], 5.1-12.1) as compared to control (2.2 mU\/mg; IQR, 1.8-3.0; P = .0003). Plasma equilibrium analysis of RAAS APs identified significant increases in the median concentrations of beneficial APs, such as angiotensin 1-7, in dogs with CHF (486.7 pg\/mL; IQR, 214.2-1168) as compared to those with preclinical disease (41.0 pg\/mL; IQR, 27.4-45.1; P\u2009&amp;lt;\u2009.0001) or control (11.4 pg\/mL; IQR, 7.1-25.3; P = .01). Incubation of plasma samples from dogs with CHF with rhACE2 increased beneficial APs, such as angiotensin 1-9 (preincubation, 10.3 pg\/mL; IQR, 4.4-37.2; postincubation, 2431\u2009pg\/mL; IQR, 1355-3037; P = .02), while simultaneously decreasing maladaptive APs, such as angiotensin II (preincubation, 53.4 pg\/mL; IQR, 28.6-226.4; postincubation, 2.4 pg\/mL; IQR, 0.50-5.8; P = .02).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Recognition of the ACE2 system expands the conventional view of the RAAS in the dog and represents an important potential therapeutic target.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.15548","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T00:29:31Z","timestamp":1561768171000},"page":"1571-1584","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Plasma and tissue angiotensin-converting enzyme 2 activity and plasma equilibrium concentrations of angiotensin peptides in dogs with heart disease"],"prefix":"10.1093","volume":"33","author":[{"given":"\u00c9va","family":"Larouche-Lebel","sequence":"first","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Clinical Sciences and Advanced Medicine, , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry A.","family":"Loughran","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Clinical Sciences and Advanced Medicine, , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5218-9226","authenticated-orcid":false,"given":"Mark A.","family":"Oyama","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Clinical Sciences and Advanced Medicine, , Philadelphia, Pennsylvania"},{"name":"Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil F.","family":"Solter","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Illinois at Urbana-Champaign Department of Pathobiology, , Urbana, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Laughlin","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Clinical Sciences and Advanced Medicine, , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa D.","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Pathobiology, , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles-Antoine","family":"Assenmacher","sequence":"additional","affiliation":[{"name":"School of Veterinary Medicine, University of Pennsylvania Department of Pathobiology, , Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4089-0573","authenticated-orcid":false,"given":"Philip R.","family":"Fox","sequence":"additional","affiliation":[{"name":"The Animal Medical Center , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Fries","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, University of Illinois at Urbana-Champaign Department of Veterinary Clinical Medicine, , Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"2026020304353533900_jvim15548-bib-0001","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1939-1676.1995.tb01092.x","article-title":"Activation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency","volume":"9","author":"Pedersen","year":"1995","journal-title":"J Vet Intern Med"},{"key":"2026020304353533900_jvim15548-bib-0002","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2460\/ajvr.1997.58.01.77","article-title":"Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs","volume":"58","author":"Haggstrom","year":"1997","journal-title":"Am J Vet Res"},{"key":"2026020304353533900_jvim15548-bib-0003","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0034-5288(95)90055-1","article-title":"Activation of the renin-angiotensin system in dogs with asymptomatic and symptomatic dilated cardiomyopathy","volume":"59","author":"Koch","year":"1995","journal-title":"Res Vet Sci"},{"key":"2026020304353533900_jvim15548-bib-0004","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"Am J Vet Res"},{"key":"2026020304353533900_jvim15548-bib-0005","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"2026020304353533900_jvim15548-bib-0006","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"key":"2026020304353533900_jvim15548-bib-0007","doi-asserted-by":"crossref","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J Biol Chem"},{"key":"2026020304353533900_jvim15548-bib-0008","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1007\/s00018-004-4240-7","article-title":"Angiotensin-converting enzyme-2: a molecular and cellular perspective","volume":"61","author":"Warner","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"2026020304353533900_jvim15548-bib-0009","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/CIRCRESAHA.116.307708","article-title":"Role of the ACE2\/angiotensin 1-7 axis of the renin-angiotensin system in heart failure","volume":"118","author":"Patel","year":"2016","journal-title":"Circ Res"},{"key":"2026020304353533900_jvim15548-bib-0010","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1007\/s00018-004-4241-6","article-title":"Physiological roles of angiotensin-converting enzyme 2","volume":"61","author":"Danilczyk","year":"2004","journal-title":"Cell Mol Life Sci"},{"key":"2026020304353533900_jvim15548-bib-0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol Rev"},{"key":"2026020304353533900_jvim15548-bib-0012","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1042\/CS20130449","article-title":"Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system","volume":"127","author":"Ocaranza","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"2026020304353533900_jvim15548-bib-0013","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.2353\/ajpath.2008.070762","article-title":"Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK\/p38 MAP kinase pathway","volume":"172","author":"Koka","year":"2008","journal-title":"Am J Pathol"},{"key":"2026020304353533900_jvim15548-bib-0014","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1939-1676.2004.tb02551.x","article-title":"Allometric scaling of M-mode cardiac measurements in normal adult dogs","volume":"18","author":"Cornell","year":"2004","journal-title":"J Vet Intern Med"},{"key":"2026020304353533900_jvim15548-bib-0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1740-8261.2002.tb01051.x","article-title":"Left atrial to aortic root indices using two-dimensional and M-mode echocardiography in cavalier King Charles spaniels with and without left atrial enlargement","volume":"43","author":"Hansson","year":"2002","journal-title":"Vet Radiol Ultrasound"},{"key":"2026020304353533900_jvim15548-bib-0016","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1939-1676.2009.0392.x","article-title":"Guidelines for the diagnosis and treatment of canine chronic valvular heart disease","volume":"23","author":"Atkins","year":"2009","journal-title":"J Vet Intern Med"},{"key":"2026020304353533900_jvim15548-bib-0017","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/jvim.14586","article-title":"Effect of pimobendan in dogs with preclinical myxomatous mitral valve disease and cardiomegaly: the EPIC study-a randomized clinical trial","volume":"30","author":"Boswood","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026020304353533900_jvim15548-bib-0018","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2016.11.064","article-title":"Roles of angiotensin peptides and recombinant human ACE2 in heart failure","volume":"69","author":"Basu","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0019","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/ndt\/gfu265","article-title":"Molecular regulation of the renin-angiotensin system in haemodialysis patients","volume":"30","author":"Kovarik","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"2026020304353533900_jvim15548-bib-0020","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1373\/clinchem.2017.278705","article-title":"Low- and high-renin heart failure phenotypes with clinical implications","volume":"64","author":"Pavo","year":"2018","journal-title":"Clin Chem"},{"key":"2026020304353533900_jvim15548-bib-0021","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.131","article-title":"Incorporation of concentration data below the limit of quantification in population pharmacokinetic analyses","volume":"3","author":"Keizer","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"2026020304353533900_jvim15548-bib-0022","first-page":"1","article-title":"Procedures for detecting outlying observations in samples","volume":"11","author":"Grubbs","year":"1969","journal-title":"Dent Tech"},{"key":"2026020304353533900_jvim15548-bib-0023","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0024","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","article-title":"Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases","volume":"77","author":"Kuba","year":"2013","journal-title":"Circ J"},{"key":"2026020304353533900_jvim15548-bib-0025","first-page":"943","article-title":"Recombinant human ACE2 and the angiotensin 1-7 axis as potential new therapies for heart failure","volume":"33","author":"Patel","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0026","first-page":"827","article-title":"Future drug discovery in renin-angiotensin-aldosterone system intervention","volume":"12","author":"Tamargo","year":"2017","journal-title":"Expert Opin Drug Discov"},{"key":"2026020304353533900_jvim15548-bib-0027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/fcp.12318","article-title":"Angiotensin-converting enzyme 2-angiotensin 1-7\/1-9 system: novel promising targets for heart failure treatment","volume":"32","author":"Kittana","year":"2018","journal-title":"Fundam Clin Pharmacol"},{"key":"2026020304353533900_jvim15548-bib-0028","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"key":"2026020304353533900_jvim15548-bib-0029","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1292\/jvms.13-0314","article-title":"Intrarenal distributions and changes of angiotensin-converting enzyme and angiotensin-converting enzyme 2 in feline and canine chronic kidney disease","volume":"76","author":"Mitani","year":"2014","journal-title":"J Vet Med Sci"},{"key":"2026020304353533900_jvim15548-bib-0030","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/JOE-13-0497","article-title":"Downregulation of the ACE2\/Ang-(1-7)\/Mas axis in transgenic mice overexpressing GH","volume":"221","author":"Munoz","year":"2014","journal-title":"J Endocrinol"},{"key":"2026020304353533900_jvim15548-bib-0031","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system","volume":"52","author":"Epelman","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0032","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1470320316668435","article-title":"Circulating ACE2 activity correlates with cardiovascular disease development","volume":"17","author":"Uri","year":"2016","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020304353533900_jvim15548-bib-0033","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","article-title":"Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes","volume":"15","author":"Epelman","year":"2009","journal-title":"J Card Fail"},{"key":"2026020304353533900_jvim15548-bib-0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One"},{"key":"2026020304353533900_jvim15548-bib-0035","doi-asserted-by":"crossref","first-page":"39353","DOI":"10.1074\/jbc.M508914200","article-title":"Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells","volume":"280","author":"Warner","year":"2005","journal-title":"J Biol Chem"},{"key":"2026020304353533900_jvim15548-bib-0036","doi-asserted-by":"crossref","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J Biol Chem"},{"key":"2026020304353533900_jvim15548-bib-0037","article-title":"Characterization of angiotensin-converting enzyme 2 ectodomain shedding from mouse proximal tubular cells","volume":"9","author":"Xiao","year":"2014","journal-title":"PLoS One"},{"key":"2026020304353533900_jvim15548-bib-0038","doi-asserted-by":"crossref","first-page":"L84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026020304353533900_jvim15548-bib-0039","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/BF03548123","article-title":"Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs","volume":"37","author":"Pedersen","year":"1996","journal-title":"Acta Vet Scand"},{"key":"2026020304353533900_jvim15548-bib-0041","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cardiores.2006.09.006","article-title":"ACE2 of the heart: from angiotensin I to angiotensin (1-7)","volume":"73","author":"Keidar","year":"2007","journal-title":"Cardiovasc Res"},{"key":"2026020304353533900_jvim15548-bib-0042","doi-asserted-by":"crossref","first-page":"H3019","DOI":"10.1152\/ajpheart.00618.2005","article-title":"Advances in the biochemical and functional roles of angiotensin converting enzyme 2 and angiotensin-(1-7) in the regulation of cardiovascular function","volume":"289","author":"Ferrario","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020304353533900_jvim15548-bib-0043","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.regpep.2009.12.020","article-title":"Angiotensin-(1-7) prevents atrial fibrosis and atrial fibrillation in long-term atrial tachycardia dogs","volume":"162","author":"Liu","year":"2010","journal-title":"Regul Pept"},{"key":"2026020304353533900_jvim15548-bib-0044","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1177\/1470320314543723","article-title":"Effects of the angiotensin-(1-7)\/Mas\/PI3K\/Akt\/nitric oxide axis and the possible role of atrial natriuretic peptide in an acute atrial tachycardia canine model","volume":"16","author":"Zhao","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020304353533900_jvim15548-bib-0045","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.yjmcc.2010.12.003","article-title":"Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure","volume":"51","author":"Iwata","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0046","doi-asserted-by":"crossref","first-page":"H498","DOI":"10.1152\/ajpheart.00102.2003","article-title":"Polymorphism in gene coding for ACE determines different development of myocardial fibrosis in rats","volume":"286","author":"Ocaranza","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026020304353533900_jvim15548-bib-0047","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.regpep.2003.12.010","article-title":"Effects of des-aspartate-angiotensin I on the actions of angiotensin III in the renal and mesenteric vasculature of normo- and hypertensive rats","volume":"120","author":"Mustafa","year":"2004","journal-title":"Regul Pept"},{"key":"2026020304353533900_jvim15548-bib-0048","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","article-title":"The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial","volume":"1","author":"BENCH (BENazepril in Canine Heart disease) Study Group","year":"1999","journal-title":"J Vet Cardiol"},{"key":"2026020304353533900_jvim15548-bib-0049","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","article-title":"Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) study group","volume":"213","author":"Ettinger","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"2026020304353533900_jvim15548-bib-0050","doi-asserted-by":"crossref","first-page":"11968","DOI":"10.1073\/pnas.93.21.11968","article-title":"Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release","volume":"93","author":"Zini","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020304353533900_jvim15548-bib-0051","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2013.04.014","article-title":"Angiotensin III: a physiological relevant peptide of the renin angiotensin system","volume":"46","author":"Yugandhar","year":"2013","journal-title":"Peptides"},{"key":"2026020304353533900_jvim15548-bib-0052","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.peptides.2011.09.015","article-title":"Angiotensin IV protects against angiotensin II-induced cardiac injury via AT4 receptor","volume":"32","author":"Yang","year":"2011","journal-title":"Peptides"},{"key":"2026020304353533900_jvim15548-bib-0053","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.peptides.2014.10.016","article-title":"Angiotensin IV stimulates high atrial stretch-induced ANP secretion via insulin regulated aminopeptidase","volume":"63","author":"Park","year":"2015","journal-title":"Peptides"},{"key":"2026020304353533900_jvim15548-bib-0054","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3317\/jraas.2001.032","article-title":"Bioactive angiotensin peptides: focus on angiotensin IV","volume":"2","author":"Mustafa","year":"2001","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2026020304353533900_jvim15548-bib-0055","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1210\/endo-100-1-46","article-title":"(des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats","volume":"100","author":"Campbell","year":"1977","journal-title":"Endocrinology"},{"key":"2026020304353533900_jvim15548-bib-0056","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1507\/endocrj1954.32.767","article-title":"Pressor activity of angiotensin II-(2-7)-hexapeptide in man","volume":"32","author":"Kono","year":"1985","journal-title":"Endocrinol Jpn"},{"key":"2026020304353533900_jvim15548-bib-0057","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.regpep.2006.12.031","article-title":"Angiotensin-(3-7) pressor effect at the rostral ventrolateral medulla","volume":"141","author":"Ferreira","year":"2007","journal-title":"Regul Pept"},{"key":"2026020304353533900_jvim15548-bib-0058","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.peptides.2016.09.009","article-title":"Angiotensin-(1-5), an active mediator of renin-angiotensin system, stimulates ANP secretion via Mas receptor","volume":"86","author":"Yu","year":"2016","journal-title":"Peptides"},{"key":"2026020304353533900_jvim15548-bib-0059","doi-asserted-by":"crossref","first-page":"823193","DOI":"10.1155\/2012\/823193","article-title":"Targeting the ACE2 and apelin pathways are novel therapies for heart failure: opportunities and challenges","volume":"2012","author":"Kazemi-Bajestani","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"2026020304353533900_jvim15548-bib-0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003315","article-title":"Targeting the cardiac myofibroblast secretome to treat myocardial fibrosis in heart failure","volume":"9","author":"Weber","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026020304353533900_jvim15548-bib-0061","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11897-013-0178-0","article-title":"Angiotensin-converting enzyme 2 as a therapeutic target for heart failure","volume":"11","author":"Chamsi-Pasha","year":"2014","journal-title":"Curr Heart Fail Rep"},{"key":"2026020304353533900_jvim15548-bib-0062","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem J"},{"key":"2026020304353533900_jvim15548-bib-0063","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","article-title":"Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects","volume":"52","author":"Haschke","year":"2013","journal-title":"Clin Pharmacokinet"},{"key":"2026020304353533900_jvim15548-bib-0064","doi-asserted-by":"crossref","first-page":"1702638","DOI":"10.1183\/13993003.02638-2017","article-title":"A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension","volume":"51","author":"Hemnes","year":"2018","journal-title":"Eur Respir J"},{"key":"2026020304353533900_jvim15548-bib-0065","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.cardfail.2013.06.296","article-title":"Increasing serum soluble angiotensin-converting enzyme 2 activity after intensive medical therapy is associated with better prognosis in acute decompensated heart failure","volume":"19","author":"Shao","year":"2013","journal-title":"J Card Fail"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvim.15548","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.15548","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.15548","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/4\/1571\/66657245\/jvim15548.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/33\/4\/1571\/66657245\/jvim15548.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T09:36:26Z","timestamp":1770111386000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/33\/4\/1571\/8447791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.15548","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"2018-12-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-18","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}